Long-term persistent donor-recipient mixed chimerism without disease recurrence after myeloablative single-unit cord blood transplantation in adult acute myeloid leukemia following myelodysplastic syndrome

Affiliations

¹ a Department of Hematology/Oncology , Institute of Medical Science, University of Tokyo , Tokyo , Japan.
² b Department of IMSUT Clinical Flow Cytometry Laboratory , Institute of Medical Science, The University of Tokyo , Tokyo , Japan.
³ c Division of Oncology, Hematology and Infectious Diseases, Department of Internal Medicine , Faculty of Medicine, Fukuoka University , Fukuoka , Japan.
⁴ d Department of Hematology/Oncology , Teikyo University School of Medicine , Tokyo , Japan.

Case Reports

Susumu Tanoue et al. Leuk Lymphoma. 2017 Dec.

. 2017 Dec;58(12):2973-2975.

doi: 10.1080/10428194.2017.1318440. Epub 2017 May 16.

¹ a Department of Hematology/Oncology , Institute of Medical Science, University of Tokyo , Tokyo , Japan.
² b Department of IMSUT Clinical Flow Cytometry Laboratory , Institute of Medical Science, The University of Tokyo , Tokyo , Japan.
³ c Division of Oncology, Hematology and Infectious Diseases, Department of Internal Medicine , Faculty of Medicine, Fukuoka University , Fukuoka , Japan.
⁴ d Department of Hematology/Oncology , Teikyo University School of Medicine , Tokyo , Japan.

No abstract available

Cited by

Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation.
Hough R, Lopes A, Patrick P, Russell N, Raj K, Tholouli E, A Snowden J, Collin M, El-Mehidi N, Lawrie A, Clifton-Hadley L, Veys P, Craddock C, Mackinnon S, Cook G, Shaw B, Marks D. Hough R, et al. Blood Adv. 2022 Apr 12;6(7):2414-2426. doi: 10.1182/bloodadvances.2021005106. Blood Adv. 2022. PMID: 34700343 Free PMC article. Clinical Trial.